Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS HFS Index gains slightly, up 0.29% in March (+1.57% YTD)

Wednesday, April 17, 2013
Opalesque Industry Update — The UCITS HFS Index continues its positive performance in 2013 with gains of 0.29% in March 2013.

The broad index started positively into the month with a performance of 0.44% after the first full week of trading and added additional returns of 0.07% in week two. Things turned around in week three though as the UCITS HFS Index dropped -0.24%, but as the last week of the month was quiet with marginal gains of 0.02% the March performance remained positive. From all funds tracked in the UCITS HFS Index 64.86% reported profits in March 2013.

From a sub-strategy perspective ten out of the twelve sub-strategies reported positive results in March, the best performing being Convertible (0.82%), Event Driven (0.74%) and CTA (0.72%). While all three made most of their gains in the first week of trading and took losses in week three, Event Driven was the only one with only marginal losses in week three (-0.01%). The worst performing strategies in March were Commodity (-0.68%) and Global Macro (-0.06%). The latter reported decent gains in week one that it gave up week by week thereafter, until finally turning negative in the last days of March. Commodity on the other hand reported losses since the beginning of the month and only saw a marginal turn around in the last week of trading with gains of 0.01%. Fixed Income (0.18%) remains the only strategy to report 16 consecutive back-to-back positive monthly results in a row. From a year to date perspective the broad UCITS HFS Index now stands at +1.57% in 2013.

The UCITS HFS Index Series is the first index family that tracks all UCITS funds using hedge fund strategies. The UCITS HFS Index Series includes all UCITS III funds that apply absolute return strategies, have more than 10 Mio. € of assets under management, offer at least weekly liquidity and have reported numbers for more than one month. Index tracking funds, long-only and 130/30 strategies are excluded. The indices are calculated on every Friday and at the end of each month by the index provider 2n20.com AG and are published on the website www.ucitsindex.com.

Press release

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for